Reuters logo
BRIEF-Quidel receives FDA clearance for Solana(R) molecular assay for detecting C. difficile infections
May 11, 2017 / 8:01 PM / 4 months ago

BRIEF-Quidel receives FDA clearance for Solana(R) molecular assay for detecting C. difficile infections

May 11 (Reuters) - Quidel Corp:

* Quidel receives FDA clearance for its new Solana(R) molecular assay for the detection of Clostridium difficile (C. difficile) infections

* Received 510(k) clearance from U.S. FDA to market its Solana C. difficile Assay for detection of Clostridium difficile (C. difficile) infections Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below